Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Venomtech to Provide Venom Discovery Arrays in Labcyte Acoustically Compatible Microplates

Published: Thursday, September 06, 2012
Last Updated: Thursday, September 06, 2012
Bookmark and Share
This new format of biological libraries uses the phylogenetically and geographically diverse Venom Discovery Arrays in Labcyte Echo® qualified microplates for acoustic dispensing.

These 384-well plates enable researchers to use the Echo® liquid handler to enhance the safety and accuracy of the manipulation of venoms.

The Acoustic Venom Discovery Array enables diverse biological samples to be screened in higher throughput with greater accuracy and simplicity with Dynamic Fluid Analysis™ on Echo systems.  Dynamic Fluid Analysis, introduced in early 2012 by Labcyte, acts in real time on a well-by-well basis to ensure a wide range of fluid types within a microplate are transferred with precision and accuracy from Echo qualified source plates.  By compensating for inherent variations in potent, biological fluids such as venoms, the Echo can handle the dispensing of the Acoustic Venom Discovery Array as it would a compound library or a natural products library in DMSO.

 “A variety of venoms have shown great utility in disease areas such as cancer, haematology, antimicrobials, immunology, growth factors and natriuresis,” said Steven Trim, founder of Venomtech. “Scientific literature is rapidly growing around the use of venom components as novel leads and therapeutics for targets such as ion channels, enzymes, GPCRs and many others.”

The Labcyte Echo liquid handler revolutionizes liquid transfer by using acoustic energy to eject fluids. The Echo allows for assay miniaturization to previously unattainable volumes, transferring 2.5 nL droplets repeatedly, so precision and accuracy are consistent over a larger volume range.  Large volume transfer is achieved by transferring several hundred droplets per second. Transfer is non-contact and tipless, with increased cost savings from elimination of tip costs and washing fluids.

Miniaturization with the Echo liquid handler retains high assay performance, allowing quantitative results at higher assay well densities.  The Echo liquid handler can be used to transfer from any source well position to any destination well position.  These can be simple fluids (media for growing cells, buffers, DMSO) or viscous solutions (lysis buffers, antibodies with glycerol, or transfection reagents and now venom).


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!